- Home
- CTXR vs XAIR Comparison
CTXR vs XAIR Comparison
Compare CTXR & XAIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTXR
- XAIR
- Stock Information
- Founded
- CTXR 2007
- XAIR 2011
- Country
- CTXR United States
- XAIR United States
- Employees
- CTXR N/A
- XAIR N/A
- Industry
- CTXR Biotechnology: Pharmaceutical Preparations
- XAIR Medical/Dental Instruments
- Sector
- CTXR Health Care
- XAIR Health Care
- Exchange
- CTXR Nasdaq
- XAIR Nasdaq
- Market Cap
- CTXR 14.6M
- XAIR 17.0M
- IPO Year
- CTXR N/A
- XAIR N/A
- Fundamental
- Price
- CTXR $1.53
- XAIR $0.16
- Analyst Decision
- CTXR Strong Buy
- XAIR Buy
- Analyst Count
- CTXR 3
- XAIR 3
- Target Price
- CTXR $53.00
- XAIR $1.50
- AVG Volume (30 Days)
- CTXR 6.7M
- XAIR 5.5M
- Earning Date
- CTXR 08-11-2025
- XAIR 06-17-2025
- Dividend Yield
- CTXR N/A
- XAIR N/A
- EPS Growth
- CTXR N/A
- XAIR N/A
- EPS
- CTXR N/A
- XAIR N/A
- Revenue
- CTXR N/A
- XAIR $3,705,000.00
- Revenue This Year
- CTXR N/A
- XAIR $286.75
- Revenue Next Year
- CTXR N/A
- XAIR $144.39
- P/E Ratio
- CTXR N/A
- XAIR N/A
- Revenue Growth
- CTXR N/A
- XAIR 219.67
- 52 Week Low
- CTXR $0.65
- XAIR $0.15
- 52 Week High
- CTXR $26.25
- XAIR $0.68
- Technical
- Relative Strength Index (RSI)
- CTXR 68.44
- XAIR 43.11
- Support Level
- CTXR $0.76
- XAIR $0.15
- Resistance Level
- CTXR $1.45
- XAIR $0.29
- Average True Range (ATR)
- CTXR 0.31
- XAIR 0.03
- MACD
- CTXR 0.06
- XAIR -0.00
- Stochastic Oscillator
- CTXR 47.63
- XAIR 7.41
About CTXR Citius Pharmaceuticals Inc.
Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.
About XAIR Beyond Air Inc.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.